Risk of malignancy in Caroli disease and syndrome: A systematic review

BACKGROUND Congenital intrahepatic bile duct dilatation without fibrosis is called Caroli disease (CD), and is called Caroli syndrome (CS) when it has fibrotic and cirrhotic liver morphology. The development of intrahepatic carcinoma is described in both conditions, but the reported incidence varies...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2020-08, Vol.26 (31), p.4718-4728
Hauptverfasser: Fahrner, Rene, Dennler, Sandra G. C., Inderbitzin, Daniel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4728
container_issue 31
container_start_page 4718
container_title World journal of gastroenterology : WJG
container_volume 26
creator Fahrner, Rene
Dennler, Sandra G. C.
Inderbitzin, Daniel
description BACKGROUND Congenital intrahepatic bile duct dilatation without fibrosis is called Caroli disease (CD), and is called Caroli syndrome (CS) when it has fibrotic and cirrhotic liver morphology. The development of intrahepatic carcinoma is described in both conditions, but the reported incidence varies extensively. Potential risk factors for the malignant transformation were not described. Furthermore, conservative or surgical treatment is performed depending on the extent of cystic malformation, hepatic dysfunction and structural hepatic changes, but little is known about which treatment should be offered to patients with CD or CS and cancer. AIM To further investigate the malignant transformation in these conditions. METHODS A systematic review of the current literature until January 2019 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. A search using Medline (PubMed) was performed using a combination of Medical Subject Headings terms "caroli disease", "caroli syndrome", "tumor", "malignant", and "cholangiocarcinoma". Only human studies published in English were used for this systematic review. The following parameters were extracted from each article: year of publication, type of study, number of patients, incidence of malignant tumor, duration of symptoms, age, sex, diagnostics, identification of tumor, surgical therapy, survival and tumor recurrence. RESULTS Twelve retrospective studies reporting the courses of 561 patients (53% females) were included in this systematic review. With a mean age of 41.6 years old (range 23 to 56 years old), patients were younger than other populations undergoing liver surgery. Depending on the size of the study population the incidence of cholangiocarcinoma varied from 2.7% to 37.5% with an overall incidence of 6.6%. There were only few detailed reports about preoperative diagnostic work-up, but a multimodal work-up including ultrasound of the liver, computed tomography, magnetic resonance imaging and endoscopic retrograde cholangiopancreatography was used in most studies. Disease duration was variable with up to several years. Most patients had episodes of cholangitis, sepsis, fever or abdominal pain. Tumor detection was an incidental finding of the surgical specimen in most cases because it is currently often impossible to detect tumor manifestation during preoperative diagnostics. Liver resection or liver transplantation was performed depending on the extent of
doi_str_mv 10.3748/wjg.v26.i31.4718
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_32884228</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2440464385</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-8c3075196b51bd5c5111da273baa3aa2ad8969dabfe26f3dc06cf5b9f007a8e33</originalsourceid><addsrcrecordid>eNqNkM9rFDEYhoModlu9e5IcBZk1vyfjQShDq0JBKPUcvkkya-pMUpPZXfa_N2XrojdP-SDP--bLg9AbSta8FfrD_n6z3jG1DpyuRUv1M7RijHYN04I8RytKSNt0nLVn6LyUe0IY55K9RGecaS0Y0yt0fRvKT5xGPMMUNhGiPeAQcQ85TQG7UDwUjyE6XA7R5TT7j_iyzmXxMyzB4ux3we9foRcjTMW_fjov0Pfrq7v-S3Pz7fPX_vKmsUKxpdGWk1bSTg2SDk5aSSl1wFo-AHAABk53qnMwjJ6pkTtLlB3l0I31I6A95xfo07H3YTvM3lkflwyTechhhnwwCYL59yaGH2aTdqYVQmpFa8G7p4Kcfm19WcwcivXTBNGnbTFMCCKU4FpWlBxRm1Mp2Y-nZygxj_pN1W-qflP1m0f9NfL27_VOgT--K6CPwN4PaSw2-Gj9CSOESNUSwXmdKOvDUhWn2KdtXGr0_f9H-W-xkKQY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2440464385</pqid></control><display><type>article</type><title>Risk of malignancy in Caroli disease and syndrome: A systematic review</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Web of Science - Science Citation Index Expanded - 2020&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Fahrner, Rene ; Dennler, Sandra G. C. ; Inderbitzin, Daniel</creator><creatorcontrib>Fahrner, Rene ; Dennler, Sandra G. C. ; Inderbitzin, Daniel</creatorcontrib><description>BACKGROUND Congenital intrahepatic bile duct dilatation without fibrosis is called Caroli disease (CD), and is called Caroli syndrome (CS) when it has fibrotic and cirrhotic liver morphology. The development of intrahepatic carcinoma is described in both conditions, but the reported incidence varies extensively. Potential risk factors for the malignant transformation were not described. Furthermore, conservative or surgical treatment is performed depending on the extent of cystic malformation, hepatic dysfunction and structural hepatic changes, but little is known about which treatment should be offered to patients with CD or CS and cancer. AIM To further investigate the malignant transformation in these conditions. METHODS A systematic review of the current literature until January 2019 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. A search using Medline (PubMed) was performed using a combination of Medical Subject Headings terms "caroli disease", "caroli syndrome", "tumor", "malignant", and "cholangiocarcinoma". Only human studies published in English were used for this systematic review. The following parameters were extracted from each article: year of publication, type of study, number of patients, incidence of malignant tumor, duration of symptoms, age, sex, diagnostics, identification of tumor, surgical therapy, survival and tumor recurrence. RESULTS Twelve retrospective studies reporting the courses of 561 patients (53% females) were included in this systematic review. With a mean age of 41.6 years old (range 23 to 56 years old), patients were younger than other populations undergoing liver surgery. Depending on the size of the study population the incidence of cholangiocarcinoma varied from 2.7% to 37.5% with an overall incidence of 6.6%. There were only few detailed reports about preoperative diagnostic work-up, but a multimodal work-up including ultrasound of the liver, computed tomography, magnetic resonance imaging and endoscopic retrograde cholangiopancreatography was used in most studies. Disease duration was variable with up to several years. Most patients had episodes of cholangitis, sepsis, fever or abdominal pain. Tumor detection was an incidental finding of the surgical specimen in most cases because it is currently often impossible to detect tumor manifestation during preoperative diagnostics. Liver resection or liver transplantation was performed depending on the extent of the biliary pathology and additional alterations of the liver structure or function. No postoperative adjuvant chemotherapy was reported, but chemotherapy was administered in selected cases of tumor recurrence. Overall survival rates after one year were low at 36% and a high recurrence rate of up to 75% during the observation period. CONCLUSION Only few retrospective studies reported a low tumor incidence. Despite the high rate of mortality and tumor recurrence, definite surgical treatment should be offered as soon as possible.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v26.i31.4718</identifier><identifier>PMID: 32884228</identifier><language>eng</language><publisher>PLEASANTON: Baishideng Publishing Group Inc</publisher><subject>Adult ; Bile Duct Neoplasms ; Bile Ducts, Intrahepatic ; Caroli Disease - diagnostic imaging ; Caroli Disease - epidemiology ; Caroli Disease - surgery ; Female ; Gastroenterology &amp; Hepatology ; Humans ; Life Sciences &amp; Biomedicine ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Retrospective Studies ; Science &amp; Technology ; Systematic Reviews ; Young Adult</subject><ispartof>World journal of gastroenterology : WJG, 2020-08, Vol.26 (31), p.4718-4728</ispartof><rights>The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.</rights><rights>The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>20</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000567043300012</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c462t-8c3075196b51bd5c5111da273baa3aa2ad8969dabfe26f3dc06cf5b9f007a8e33</citedby><cites>FETCH-LOGICAL-c462t-8c3075196b51bd5c5111da273baa3aa2ad8969dabfe26f3dc06cf5b9f007a8e33</cites><orcidid>0000-0002-6098-9338 ; 0000-0002-7129-5905 ; 0000-0002-8020-0349</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445861/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445861/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,28253,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32884228$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fahrner, Rene</creatorcontrib><creatorcontrib>Dennler, Sandra G. C.</creatorcontrib><creatorcontrib>Inderbitzin, Daniel</creatorcontrib><title>Risk of malignancy in Caroli disease and syndrome: A systematic review</title><title>World journal of gastroenterology : WJG</title><addtitle>WORLD J GASTROENTERO</addtitle><addtitle>World J Gastroenterol</addtitle><description>BACKGROUND Congenital intrahepatic bile duct dilatation without fibrosis is called Caroli disease (CD), and is called Caroli syndrome (CS) when it has fibrotic and cirrhotic liver morphology. The development of intrahepatic carcinoma is described in both conditions, but the reported incidence varies extensively. Potential risk factors for the malignant transformation were not described. Furthermore, conservative or surgical treatment is performed depending on the extent of cystic malformation, hepatic dysfunction and structural hepatic changes, but little is known about which treatment should be offered to patients with CD or CS and cancer. AIM To further investigate the malignant transformation in these conditions. METHODS A systematic review of the current literature until January 2019 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. A search using Medline (PubMed) was performed using a combination of Medical Subject Headings terms "caroli disease", "caroli syndrome", "tumor", "malignant", and "cholangiocarcinoma". Only human studies published in English were used for this systematic review. The following parameters were extracted from each article: year of publication, type of study, number of patients, incidence of malignant tumor, duration of symptoms, age, sex, diagnostics, identification of tumor, surgical therapy, survival and tumor recurrence. RESULTS Twelve retrospective studies reporting the courses of 561 patients (53% females) were included in this systematic review. With a mean age of 41.6 years old (range 23 to 56 years old), patients were younger than other populations undergoing liver surgery. Depending on the size of the study population the incidence of cholangiocarcinoma varied from 2.7% to 37.5% with an overall incidence of 6.6%. There were only few detailed reports about preoperative diagnostic work-up, but a multimodal work-up including ultrasound of the liver, computed tomography, magnetic resonance imaging and endoscopic retrograde cholangiopancreatography was used in most studies. Disease duration was variable with up to several years. Most patients had episodes of cholangitis, sepsis, fever or abdominal pain. Tumor detection was an incidental finding of the surgical specimen in most cases because it is currently often impossible to detect tumor manifestation during preoperative diagnostics. Liver resection or liver transplantation was performed depending on the extent of the biliary pathology and additional alterations of the liver structure or function. No postoperative adjuvant chemotherapy was reported, but chemotherapy was administered in selected cases of tumor recurrence. Overall survival rates after one year were low at 36% and a high recurrence rate of up to 75% during the observation period. CONCLUSION Only few retrospective studies reported a low tumor incidence. Despite the high rate of mortality and tumor recurrence, definite surgical treatment should be offered as soon as possible.</description><subject>Adult</subject><subject>Bile Duct Neoplasms</subject><subject>Bile Ducts, Intrahepatic</subject><subject>Caroli Disease - diagnostic imaging</subject><subject>Caroli Disease - epidemiology</subject><subject>Caroli Disease - surgery</subject><subject>Female</subject><subject>Gastroenterology &amp; Hepatology</subject><subject>Humans</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local</subject><subject>Retrospective Studies</subject><subject>Science &amp; Technology</subject><subject>Systematic Reviews</subject><subject>Young Adult</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>EIF</sourceid><recordid>eNqNkM9rFDEYhoModlu9e5IcBZk1vyfjQShDq0JBKPUcvkkya-pMUpPZXfa_N2XrojdP-SDP--bLg9AbSta8FfrD_n6z3jG1DpyuRUv1M7RijHYN04I8RytKSNt0nLVn6LyUe0IY55K9RGecaS0Y0yt0fRvKT5xGPMMUNhGiPeAQcQ85TQG7UDwUjyE6XA7R5TT7j_iyzmXxMyzB4ux3we9foRcjTMW_fjov0Pfrq7v-S3Pz7fPX_vKmsUKxpdGWk1bSTg2SDk5aSSl1wFo-AHAABk53qnMwjJ6pkTtLlB3l0I31I6A95xfo07H3YTvM3lkflwyTechhhnwwCYL59yaGH2aTdqYVQmpFa8G7p4Kcfm19WcwcivXTBNGnbTFMCCKU4FpWlBxRm1Mp2Y-nZygxj_pN1W-qflP1m0f9NfL27_VOgT--K6CPwN4PaSw2-Gj9CSOESNUSwXmdKOvDUhWn2KdtXGr0_f9H-W-xkKQY</recordid><startdate>20200821</startdate><enddate>20200821</enddate><creator>Fahrner, Rene</creator><creator>Dennler, Sandra G. C.</creator><creator>Inderbitzin, Daniel</creator><general>Baishideng Publishing Group Inc</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6098-9338</orcidid><orcidid>https://orcid.org/0000-0002-7129-5905</orcidid><orcidid>https://orcid.org/0000-0002-8020-0349</orcidid></search><sort><creationdate>20200821</creationdate><title>Risk of malignancy in Caroli disease and syndrome: A systematic review</title><author>Fahrner, Rene ; Dennler, Sandra G. C. ; Inderbitzin, Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-8c3075196b51bd5c5111da273baa3aa2ad8969dabfe26f3dc06cf5b9f007a8e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Bile Duct Neoplasms</topic><topic>Bile Ducts, Intrahepatic</topic><topic>Caroli Disease - diagnostic imaging</topic><topic>Caroli Disease - epidemiology</topic><topic>Caroli Disease - surgery</topic><topic>Female</topic><topic>Gastroenterology &amp; Hepatology</topic><topic>Humans</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local</topic><topic>Retrospective Studies</topic><topic>Science &amp; Technology</topic><topic>Systematic Reviews</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Fahrner, Rene</creatorcontrib><creatorcontrib>Dennler, Sandra G. C.</creatorcontrib><creatorcontrib>Inderbitzin, Daniel</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fahrner, Rene</au><au>Dennler, Sandra G. C.</au><au>Inderbitzin, Daniel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of malignancy in Caroli disease and syndrome: A systematic review</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><stitle>WORLD J GASTROENTERO</stitle><addtitle>World J Gastroenterol</addtitle><date>2020-08-21</date><risdate>2020</risdate><volume>26</volume><issue>31</issue><spage>4718</spage><epage>4728</epage><pages>4718-4728</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>BACKGROUND Congenital intrahepatic bile duct dilatation without fibrosis is called Caroli disease (CD), and is called Caroli syndrome (CS) when it has fibrotic and cirrhotic liver morphology. The development of intrahepatic carcinoma is described in both conditions, but the reported incidence varies extensively. Potential risk factors for the malignant transformation were not described. Furthermore, conservative or surgical treatment is performed depending on the extent of cystic malformation, hepatic dysfunction and structural hepatic changes, but little is known about which treatment should be offered to patients with CD or CS and cancer. AIM To further investigate the malignant transformation in these conditions. METHODS A systematic review of the current literature until January 2019 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. A search using Medline (PubMed) was performed using a combination of Medical Subject Headings terms "caroli disease", "caroli syndrome", "tumor", "malignant", and "cholangiocarcinoma". Only human studies published in English were used for this systematic review. The following parameters were extracted from each article: year of publication, type of study, number of patients, incidence of malignant tumor, duration of symptoms, age, sex, diagnostics, identification of tumor, surgical therapy, survival and tumor recurrence. RESULTS Twelve retrospective studies reporting the courses of 561 patients (53% females) were included in this systematic review. With a mean age of 41.6 years old (range 23 to 56 years old), patients were younger than other populations undergoing liver surgery. Depending on the size of the study population the incidence of cholangiocarcinoma varied from 2.7% to 37.5% with an overall incidence of 6.6%. There were only few detailed reports about preoperative diagnostic work-up, but a multimodal work-up including ultrasound of the liver, computed tomography, magnetic resonance imaging and endoscopic retrograde cholangiopancreatography was used in most studies. Disease duration was variable with up to several years. Most patients had episodes of cholangitis, sepsis, fever or abdominal pain. Tumor detection was an incidental finding of the surgical specimen in most cases because it is currently often impossible to detect tumor manifestation during preoperative diagnostics. Liver resection or liver transplantation was performed depending on the extent of the biliary pathology and additional alterations of the liver structure or function. No postoperative adjuvant chemotherapy was reported, but chemotherapy was administered in selected cases of tumor recurrence. Overall survival rates after one year were low at 36% and a high recurrence rate of up to 75% during the observation period. CONCLUSION Only few retrospective studies reported a low tumor incidence. Despite the high rate of mortality and tumor recurrence, definite surgical treatment should be offered as soon as possible.</abstract><cop>PLEASANTON</cop><pub>Baishideng Publishing Group Inc</pub><pmid>32884228</pmid><doi>10.3748/wjg.v26.i31.4718</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-6098-9338</orcidid><orcidid>https://orcid.org/0000-0002-7129-5905</orcidid><orcidid>https://orcid.org/0000-0002-8020-0349</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2020-08, Vol.26 (31), p.4718-4728
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmed_primary_32884228
source MEDLINE; Baishideng "World Journal of" online journals; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adult
Bile Duct Neoplasms
Bile Ducts, Intrahepatic
Caroli Disease - diagnostic imaging
Caroli Disease - epidemiology
Caroli Disease - surgery
Female
Gastroenterology & Hepatology
Humans
Life Sciences & Biomedicine
Male
Middle Aged
Neoplasm Recurrence, Local
Retrospective Studies
Science & Technology
Systematic Reviews
Young Adult
title Risk of malignancy in Caroli disease and syndrome: A systematic review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T16%3A15%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20malignancy%20in%20Caroli%20disease%20and%20syndrome:%20A%20systematic%20review&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Fahrner,%20Rene&rft.date=2020-08-21&rft.volume=26&rft.issue=31&rft.spage=4718&rft.epage=4728&rft.pages=4718-4728&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v26.i31.4718&rft_dat=%3Cproquest_pubme%3E2440464385%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2440464385&rft_id=info:pmid/32884228&rfr_iscdi=true